Cellestan-ImmunoQuant Inc. (CIQ) is a leading provider of antibodies and custom immunohistochemistry services for life science researchers. With a focus on apoptosis and cell signaling, CIQ offers a comprehensive range of high-quality antibodies that have been thoroughly tested and highly published. Their expertise in immunocyto- and immunohistochemical tissue investigation allows them to provide reliable searching tools for projects, including the construction of Tissue MicroArrays (TMAs) for high-throughput screenings. CIQ also offers custom IHC digital imaging services, co-localization of antigens, and digital pathology IHC quantification.
With almost three decades of experience in diagnostic histopathology and immunohistochemistry, the founders of CIQ have a deep understanding of pathology and microscopic imaging. They have developed well-tested standard operating procedures for selecting the best tissue sections and IHC detection methods, ensuring optimal staining results. CIQ's commitment to quality is reflected in their extensive publication record and the value of their antibodies as protein biomarkers. Whether researchers need research size, bulk, or large volumes of antibodies, CIQ is dedicated to enhancing the efficiency and effectiveness of life science research worldwide.
Generated from the website